AlloDerm is a tissue implant introduced in 1994 to help treat burn victims. Today, AlloDerm is used in hernia, facial and breast reconstruction surgeries to replace damaged soft tissue. AlloDerm tissue matrix is made by LifeCell from donated human skin tissue that has been processed to remove the tissue antigens. AlloDerm promotes tissue growth and is claimed to reduce risk of tissue rejection and graft failure. However, complications can occur, such as infection and tissue rejection. If you suspect you are having a complication following AlloDerm implantation, seek medical attention immediately.